These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35022831)

  • 1. Successful IL-17A inhibitor cycling in psoriatic arthritis patient: a case report and a literature review.
    Barešić M; Smiljanić Tomičević L; Anić B; Mayer M
    Rheumatol Int; 2022 Feb; 42(2):365-370. PubMed ID: 35022831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ixekizumab: an anti- IL-17A monoclonal antibody for the treatment of psoriatic arthritis.
    Toussirot E
    Expert Opin Biol Ther; 2018 Jan; 18(1):101-107. PubMed ID: 29187009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ixekizumab therapy following secukinumab inadequate response in psoriatic arthritis: a case series focusing on axial disease.
    Panagiotopoulos A; Koutsianas C; Kougkas N; Moschou D; Bournia VK; Gazi S; Tektonidou MG; Vassilopoulos D; Sfikakis PP; Fragoulis GE
    Rheumatol Int; 2023 May; 43(5):969-973. PubMed ID: 36840819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52-week, open-label, phase 3 study (UNCOVER-J).
    Saeki H; Nakagawa H; Nakajo K; Ishii T; Morisaki Y; Aoki T; Cameron GS; Osuntokun OO;
    J Dermatol; 2017 Apr; 44(4):355-362. PubMed ID: 27726163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ixekizumab for treatment of adults with moderate-to-severe plaque psoriasis and psoriatic arthritis.
    Vu TT; Gooderham M; Papp K
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1423-1433. PubMed ID: 27690669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secukinumab: IL-17A inhibition to treat psoriatic arthritis.
    Speeckaert R; van Geel N; Lambert J; Claeys L; Delanghe JR; Speeckaert MM
    Drugs Today (Barc); 2016 Nov; 52(11):607-616. PubMed ID: 28112279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Overview of Bimekizumab for the Treatment of Psoriatic Arthritis: The Evidence so Far.
    Oliveira DG; Faria R; Torres T
    Drug Des Devel Ther; 2021; 15():1045-1053. PubMed ID: 33727793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ixekizumab for the treatment of psoriasis: an update on new data since first approval.
    Blegvad C; Skov L; Zachariae C
    Expert Rev Clin Immunol; 2019 Feb; 15(2):111-121. PubMed ID: 30589394
    [No Abstract]   [Full Text] [Related]  

  • 9. The safety of ixekizumab in psoriasis drug therapy.
    Puig L
    Expert Opin Drug Saf; 2020 Feb; 19(2):117-130. PubMed ID: 31874129
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-IL-17 Medications Used in the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review.
    Canavan TN; Elmets CA; Cantrell WL; Evans JM; Elewski BE
    Am J Clin Dermatol; 2016 Feb; 17(1):33-47. PubMed ID: 26649440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subacute thyroiditis in a patient with psoriatic arthritis switched from secukinumab to adalimumab: a case report and literature review.
    Nakagawa J; Fujikawa K; Akagi M; Nakaji K; Yasui J; Hanatani Y; Hara T; Mizokami A; Kawakami A
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):36-39. PubMed ID: 32731788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes.
    McInnes IB; Sawyer LM; Markus K; LeReun C; Sabry-Grant C; Helliwell PS
    RMD Open; 2022 Mar; 8(1):. PubMed ID: 35321874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial.
    McInnes IB; Mease PJ; Kirkham B; Kavanaugh A; Ritchlin CT; Rahman P; van der Heijde D; Landewé R; Conaghan PG; Gottlieb AB; Richards H; Pricop L; Ligozio G; Patekar M; Mpofu S;
    Lancet; 2015 Sep; 386(9999):1137-46. PubMed ID: 26135703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secukinumab for the treatment of psoriatic arthritis.
    Baronaite Hansen R; Kavanaugh A
    Expert Rev Clin Immunol; 2016 Oct; 12(10):1027-36. PubMed ID: 27550397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ixekizumab in the treatment of psoriatic arthritis.
    Lespessailles E; Toumi H
    Immunotherapy; 2021 Jan; 13(1):19-33. PubMed ID: 33167745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secukinumab (AIN-457) for the treatment of Psoriasis.
    Jaleel T; Elmets C; Weinkle A; Kassira S; Elewski B
    Expert Rev Clin Pharmacol; 2016; 9(2):187-202. PubMed ID: 26647300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of psoriatic arthritis with secukinumab: a case series.
    Nicola S; Rolla G; Monti R; Brussino L
    J Dermatolog Treat; 2018; 29(sup1):6-8. PubMed ID: 30247936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriatic arthritis for dermatologists.
    Gottlieb A; Merola JF
    J Dermatolog Treat; 2020 Nov; 31(7):662-679. PubMed ID: 31014154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study.
    Perrotta FM; Delle Sedie A; Scriffignano S; Volpe P; Cordisco E; Milano N; Gabini M; Lubrano E
    Reumatismo; 2020 Apr; 72(1):52-59. PubMed ID: 32292021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secukinumab Improves Physical Function in Subjects With Plaque Psoriasis and Psoriatic Arthritis: Results from Two Randomized, Phase 3 Trials.
    Gottlieb AB; Langley RG; Philipp S; Sigurgeirsson B; Blauvelt A; Martin R; Papavassilis C; Mpofu S
    J Drugs Dermatol; 2015 Aug; 14(8):821-33. PubMed ID: 26267726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.